AET - CVS: Going Long And Understanding The Aetna Deal
CVS Health Inc. (CVS) is a company we have been watching for some time now.
We had initially considered going long during the second half of 2017 while the shares traded around $70.
Instead, we held off owing to the overhang of the pending Aetna (AET) acquisition, feeling pretty sure that CVS was overpaying for the deal and that the stock would more than likely sell-off at some point following from that.
In this post, I'll explain how we reached the conclusion that CVS made for a good trade in the